Logo image of FOSL

FOSSIL GROUP INC (FOSL) Stock Fundamental Analysis

USA - NASDAQ:FOSL - US34988V1061 - Common Stock

2.5 USD
+0.12 (+5.04%)
Last: 10/20/2025, 8:00:01 PM
2.45 USD
-0.05 (-2%)
After Hours: 10/20/2025, 8:00:01 PM
Fundamental Rating

1

FOSL gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. FOSL has a bad profitability rating. Also its financial health evaluation is rather negative. FOSL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

FOSL had negative earnings in the past year.
FOSL had a negative operating cash flow in the past year.
In the past 5 years FOSL reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: FOSL reported negative operating cash flow in multiple years.
FOSL Yearly Net Income VS EBIT VS OCF VS FCFFOSL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

FOSL's Return On Assets of -8.44% is on the low side compared to the rest of the industry. FOSL is outperformed by 77.08% of its industry peers.
With a Return On Equity value of -39.57%, FOSL is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 4.80%, FOSL is doing worse than 64.58% of the companies in the same industry.
Industry RankSector Rank
ROA -8.44%
ROE -39.57%
ROIC 4.8%
ROA(3y)-11.03%
ROA(5y)-7.54%
ROE(3y)-47.24%
ROE(5y)-31.62%
ROIC(3y)N/A
ROIC(5y)N/A
FOSL Yearly ROA, ROE, ROICFOSL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

Looking at the Operating Margin, with a value of 2.44%, FOSL is doing worse than 68.75% of the companies in the same industry.
Looking at the Gross Margin, with a value of 55.74%, FOSL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of FOSL has remained more or less at the same level.
Industry RankSector Rank
OM 2.44%
PM (TTM) N/A
GM 55.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y1.27%
FOSL Yearly Profit, Operating, Gross MarginsFOSL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FOSL is destroying value.
FOSL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for FOSL has been increased compared to 5 years ago.
The debt/assets ratio for FOSL is higher compared to a year ago.
FOSL Yearly Shares OutstandingFOSL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
FOSL Yearly Total Debt VS Total AssetsFOSL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

FOSL has an Altman-Z score of 1.97. This is not the best score and indicates that FOSL is in the grey zone with still only limited risk for bankruptcy at the moment.
FOSL has a Altman-Z score of 1.97. This is in the lower half of the industry: FOSL underperforms 77.08% of its industry peers.
A Debt/Equity ratio of 1.10 is on the high side and indicates that FOSL has dependencies on debt financing.
FOSL has a Debt to Equity ratio of 1.10. This is in the lower half of the industry: FOSL underperforms 72.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACC0.39
WACC12.43%
FOSL Yearly LT Debt VS Equity VS FCFFOSL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

FOSL has a Current Ratio of 1.83. This is a normal value and indicates that FOSL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of FOSL (1.83) is comparable to the rest of the industry.
FOSL has a Quick Ratio of 1.17. This is a normal value and indicates that FOSL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.17, FOSL is in line with its industry, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.17
FOSL Yearly Current Assets VS Current LiabilitesFOSL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.39% over the past year.
FOSL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.34%.
The Revenue for FOSL have been decreasing by -12.38% on average. This is quite bad
EPS 1Y (TTM)61.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.72%
Revenue 1Y (TTM)-15.34%
Revenue growth 3Y-15.08%
Revenue growth 5Y-12.38%
Sales Q2Q%-15.23%

3.2 Future

The Earnings Per Share is expected to grow by 29.64% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -10.68% on average over the next years. This is quite bad
EPS Next Y-101.51%
EPS Next 2Y37.65%
EPS Next 3Y29.64%
EPS Next 5YN/A
Revenue Next Year-13.86%
Revenue Next 2Y-16.12%
Revenue Next 3Y-10.68%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
FOSL Yearly Revenue VS EstimatesFOSL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
FOSL Yearly EPS VS EstimatesFOSL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2023 2025 2026 2027 0 2 -2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FOSL. In the last year negative earnings were reported.
Also next year FOSL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FOSL Price Earnings VS Forward Price EarningsFOSL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FOSL is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.88
FOSL Per share dataFOSL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

FOSL's earnings are expected to grow with 29.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.65%
EPS Next 3Y29.64%

0

5. Dividend

5.1 Amount

No dividends for FOSL!.
Industry RankSector Rank
Dividend Yield N/A

FOSSIL GROUP INC

NASDAQ:FOSL (10/20/2025, 8:00:01 PM)

After market: 2.45 -0.05 (-2%)

2.5

+0.12 (+5.04%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-05 2025-11-05
Inst Owners48.81%
Inst Owner Change0%
Ins Owners2.05%
Ins Owner Change0.05%
Market Cap134.47M
Analysts82.86
Price Target5.1 (104%)
Short Float %9.86%
Short Ratio6.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 0.9
EV/EBITDA 4.88
EPS(TTM)-1.12
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS20.15
BVpS2.79
TBVpS2.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.44%
ROE -39.57%
ROCE 6.07%
ROIC 4.8%
ROICexc 6.42%
ROICexgc 6.44%
OM 2.44%
PM (TTM) N/A
GM 55.74%
FCFM N/A
ROA(3y)-11.03%
ROA(5y)-7.54%
ROE(3y)-47.24%
ROE(5y)-31.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y1.27%
F-Score3
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA 4.1
Cap/Depr 31.55%
Cap/Sales 0.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.17
Altman-Z 1.97
F-Score3
WACC12.43%
ROIC/WACC0.39
Cap/Depr(3y)47.98%
Cap/Depr(5y)39.78%
Cap/Sales(3y)0.66%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.72%
EPS Next Y-101.51%
EPS Next 2Y37.65%
EPS Next 3Y29.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.34%
Revenue growth 3Y-15.08%
Revenue growth 5Y-12.38%
Sales Q2Q%-15.23%
Revenue Next Year-13.86%
Revenue Next 2Y-16.12%
Revenue Next 3Y-10.68%
Revenue Next 5YN/A
EBIT growth 1Y135.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.53%
EBIT Next 3Y52.14%
EBIT Next 5YN/A
FCF growth 1Y-14.84%
FCF growth 3Y0.19%
FCF growth 5YN/A
OCF growth 1Y-53.88%
OCF growth 3Y-2.26%
OCF growth 5YN/A